Catena Biosciences

Catena Biosciences' Catenase platform conjugates proteins by forming a novel type of covalent bond between naturally occurring amino acids, which can be used to create targeted therapeutic methods. This unique patented technology allows for the construction of biomolecules that current modern manufacturing techniques cannot achieve. Initially focused on oncology, the platform has now been applied across multiple therapeutic areas.